Mulmit

Amylyx Pharmaceuticals, Inc.Amylyx Pharmaceuticals, Inc.

AMLX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-310-153,291,000-144,735,000-1.53
2024-12-3187,371,000-314,731,000-301,743,000-4.43
2023-12-31380,786,00038,802,00049,271,0000.7
2022-12-3122,230,000-201,341,000-198,375,000-3.39

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-31Firestone Karen25,000
2026-08-31Firestone Karen25,000
2026-08-31Firestone Karen25,000
2026-08-31Firestone Karen25,000
2026-08-18FRATES JAMES MChief Financial Officer22,807
2026-08-18Klee Justin B.Co-Chief Executive Officer60,039
2026-08-18Mazzariello GinaChief Legal Officer21,284
2026-08-18Bedrosian Camille LChief Medical Officer22,807
2026-08-18Cohen Joshua BCo-Chief Executive Officer60,039
2026-07-10Mazzariello GinaChief Legal Officer15,000
2026-07-09Mazzariello GinaChief Legal Officer15,000
2026-06-04Zeiher Bernhardt G24,372

8-K events

FiledItems
2026-08-20Entry into a material agreement · Financial statements and exhibits
2026-08-18Other events · Financial statements and exhibits
2026-08-18Regulation FD disclosure · Other events · Financial statements and exhibits
2026-08-06Results of operations · Financial statements and exhibits
2026-06-04Submission of matters to a vote
2026-05-07Results of operations · Financial statements and exhibits
2026-03-24Regulation FD disclosure · Financial statements and exhibits
2026-03-03Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.